CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) AND DRIVERS OF ANTIEMETIC PRESCRIBING: RESULTS OF A QUALITATIVE IN-PRACTICE STUDY OF CLINICIANS FROM VARIOUS SETTINGS

被引：0
|
作者：
LeBlanc, T. W. [1 ]
D'Agostino, P. [2 ]
Ruffo, P. [2 ]
Turini, M. [2 ]
Harmon, A. L. [3 ]
Ortendahl, J. D. [3 ]
机构：
[1] Duke Canc Inst, Durham, NC USA
[2] Helsinn Healthcare SA, Lugano, Switzerland
[3] Partnership Hlth Analyt Res LLC, Beverly Hills, CA USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.331
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN249
引用
收藏
页码：S56 / S56
页数：1
相关论文
共 50 条
  • [31] Evaluation of practice patterns for prevention of chemotherapy (CT)-induced nausea and vomiting (CINV) and antiemetic guidelines (GLs) adherence based on real-world prescribing data
    Aapro, M. S.
    Scotte, F.
    Escobar, Y.
    Celio, L.
    Berman, R. D.
    Franceschetti, A.
    Bell, D.
    Jordan, K.
    ANNALS OF ONCOLOGY, 2018, 29
  • [32] Region-wide professional practice evaluation with regards to antiemetic prescription into chemotherapy-induced nausea and vomiting
    Tavernier, Jerome
    Jouannet-Romaszko, Mireille
    Bertucat, Helena
    Marchiset, Nathalie
    Bahadoor, Mohum
    Chevrier, Regine
    BULLETIN DU CANCER, 2016, 103 (7-8) : 622 - 631
  • [33] Transferability to clinical practice of the results of controlled clinical trials: The case of antiemetic prophylactic treatment for cancer chemotherapy-induced nausea and vomiting
    Del Favero, A
    Roila, F
    De Angelis, V
    Tonato, M
    Ballatori, E
    Tumolo, S
    Meneghetti, L
    Negri, D
    Della Gaspera, S
    Presot, C
    Muran, G
    Lucenti, A
    Ciccarese, G
    Palladino, MA
    Porrozzi, S
    Sabbatini, R
    Depenni, R
    Federico, M
    Silingardi, V
    Sansoni, E
    Maltoni, M
    Milandri, C
    Amadori, D
    Sabbioni, R
    Nortilli, R
    Cetto, GL
    Dogliotti, L
    Buniva, T
    Gorzegno, G
    Lopez, M
    Amodio, A
    Conti, F
    Foggi, CM
    Giglio, A
    De Sio, L
    Manente, P
    Bernardo, G
    Strada, MR
    Villani, G
    Gallo, L
    Merlini, L
    Caroti, C
    Mazzotta, S
    Forcignano, R
    Quarta, G
    Pacilio, C
    Iodice, G
    Rosati, G
    Malacarne, P
    Donati, D
    ANNALS OF ONCOLOGY, 1998, 9 (07) : 759 - 765
  • [34] Olanzapine for Chemotherapy-Induced Nausea and Vomiting (CINV) Prophylaxis in Children: A Multi-Centre Feasibility Study
    Dupuis, L. L.
    Schechter, T.
    Gibson, P.
    Johnston, D.
    Orsey, A.
    Portwine, C.
    Sung, L.
    Flank, J.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S278 - S278
  • [35] PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) WITH NEPA, THE FIRST ORAL COMBINATION ANTIEMETIC, IN PATIENTS WITH GYNECOLOGICAL CANCERS RECEIVING PLATINUM-BASED CHEMOTHERAPY
    Bosnjak, S.
    Stamatovic, L.
    Jordan, K.
    Rizzi, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 582 - 583
  • [36] Improving the care of patients with regard to chemotherapy-induced nausea and emesis: The effect of feedback to clinicians on adherence to antiemetic prescribing guidelines
    Mertens, WC
    Higby, DJ
    Brown, D
    Parisi, R
    Fitzgerald, J
    Benjamin, EM
    Lindenauer, PK
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (07) : 1373 - 1378
  • [37] Impact of chemotherapy-induced nausea and vomiting (CINV) on emergency department (ED) visits and disruption of chemotherapy: results of a survey of oncology nurses
    Rittenberg, C.
    Clark-Snow, R.
    Affronti, M. L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [38] Comparison of yoga versus relaxation on chemotherapy-induced nausea and vomiting (CINV) outcomes a mechanism of action study.
    Raghavendra, Rao M.
    Usharani, Malur R.
    Kavya, Mahesh
    Aishvarrya, S.
    Nandini, Pkl
    Patil, Shekhar
    Ravi, Diwakar B.
    Shashidhara, H. P.
    Satheesh, C. T.
    Radheshyam, Nayak
    Ajaikumar, Basavalinga S.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [39] Cost-effectiveness analysis of olanzapine-containing antiemetic therapy for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) in highly emetogenic chemotherapy (HEC) patients
    Ronald Chow
    Leonard Chiu
    Jørn Herrstedt
    Matti Aapro
    Michael Lock
    Carlo DeAngelis
    Rudolph M. Navari
    Supportive Care in Cancer, 2021, 29 : 4269 - 4275
  • [40] Cost-effectiveness analysis of olanzapine-containing antiemetic therapy for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) in highly emetogenic chemotherapy (HEC) patients
    Chow, Ronald
    Chiu, Leonard
    Herrstedt, Jorn
    Aapro, Matti
    Lock, Michael
    DeAngelis, Carlo
    Navari, Rudolph M.
    SUPPORTIVE CARE IN CANCER, 2021, 29 (08) : 4269 - 4275
12345